2009/04/13 by Jongmin Jeon, Mayrin Correa-Medina, Camillo Ricordi +3 · 204 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Biology #Cell biology #Cellular differentiation #Diabetes Management and Research #Diabetes and associated disorders #Embryonic stem cell #Endocrine system #Endocrinology #Enteroendocrine cell #Fetus #Gene expression #Genetics #Glucagon #Hormone #Immunohistochemistry #Immunology #Immunostaining #In situ hybridization #In vitro #Insulin #Internal medicine #Islet #Medicine #Pancreas #Pancreatic function and diabetes #Pregnancy #Progenitor cell #Stem cell
paper · open access · doi:10.1369/jhc.2009.953307
published in Journal of Histochemistry & Cytochemistry 57(9), 811-824 (SAGE Publishing)
openalex publication_date 2009/04/13 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29
The development of efficient, reproducible protocols for directed in vitro differentiation of human embryonic stem (hES) cells into insulin-producing beta cells will benefit greatly from increased knowledge regarding the spatiotemporal expression profile of key instructive factors involved in human endocrine cell generation. Human fetal pancreases 7 to 21 weeks of gestational age, were collected following consent immediately after pregnancy termination and processed for immunostaining, in situ hybridization, and real-time RT-PCR expression analyses. Islet-like structures appear from approximately week 12 and, unlike the mixed architecture observed in adult islets, fetal islets are initially formed predominantly by aggregated insulin- or glucagon-expressing cells. The period studied (7-22 weeks) coincides with a decrease in the proliferation and an increase in the differentiation of the progenitor cells, the initiation of NGN3 expression, and the appearance of differentiated endocrine cells. The present study provides a detailed characterization of islet formation and expression profiles of key intrinsic and extrinsic factors during human pancreas development. This information is beneficial for the development of efficient protocols that will allow guided in vitro differentiation of hES cells into insulin-producing cells.